Parkman Healthcare Partners LLC - 06 Oct 2025 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Reporting relationship: 10%+ Owner
Issuer ticker: SPRB
Reported as of: 06 Oct 2025
Net transaction value: -$335
SEC form: 4
Accepted by SEC: 15 Oct 2025, 16:32:43 UTC
Source filing: View source filing
Reporting owner signature: Parkman Healthcare Partners LLC, By: /s/ Gregory Martinez, Chief Investment Officer

Key filing fact

Parkman Healthcare Partners LLC filed Form 4 for SPRUCE BIOSCIENCES, INC. (SPRB) on 15 Oct 2025.

Key facts

This page summarizes Parkman Healthcare Partners LLC's Form 4 filing for SPRUCE BIOSCIENCES, INC. (SPRB).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 Oct 2025, 16:32.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$335.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001777015 Primary reporting owner

Parkman Healthcare Partners LLC

Relationship: 10%+ Owner
Address: 700 CANAL STREET, STAMFORD
Signature: Parkman Healthcare Partners LLC, By: /s/ Gregory Martinez, Chief Investment Officer
Signature date: 15 Oct 2025

CIK 0002091748

Martinez Gregory

Relationship: 10%+ Owner
Address: 700 CANAL STREET, STAMFORD
Signature: /s/ Gregory Martinez
Signature date: 15 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPRB transaction

Common Stock, $0.001 par value per share

Purchase

Transaction value: $4,585
Shares: +256
Change %: +24%
Price: $17.91
Shares after: 1,307
Date: 06 Oct 2025
Ownership: See footnote
Footnotes: F1, F2

SPRB transaction

Common Stock, $0.001 par value per share

Sale

Transaction value: $4,484
Shares: -232
Change %: -18%
Price: $19.33
Shares after: 1,075
Date: 06 Oct 2025
Ownership: See footnote
Footnotes: F2, F3

SPRB transaction

Common Stock, $0.001 par value per share

Sale

Transaction value: $436
Shares: -25
Change %: -2.3%
Price: $17.46
Shares after: 1,050
Date: 06 Oct 2025
Ownership: See footnote
Footnotes: F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Parkman Healthcare Partners LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $17.55 to $18. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Footnote F2

The amount reported represents the Reporting Persons' pecuniary interest held through an investment in private funds. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $19.125 to $19.63. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $17.44 to $17.56. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC remarks

As previously disclosed in Parkman Healthcare Partners LLC's Form 4 with respect to the Issuer filed on October 8, 2025, these securities are also indirectly beneficially owned by Gregory Martinez.